Revvity Share Price (NYSE: RVTY)

$90.14

▲

0.91

(1.02%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Revvity Stock chart to analyse performance

Revvity stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$89.04
Today's High:$90.29
$90.14
1.22%
Downside
Day's Volatility :1.38%
Upside
0.17%
52 Weeks Low:$85.12
52 Weeks High:$129.50
$90.14
5.57%
Downside
52 Weeks Volatility :34.27%
Upside
30.39%

Revvity Stock Returns

Period	Revvity Inc	Index (Russel 2000)
3 Months	0.92%	0.0%
6 Months	-18.34%	0.0%
1 Year	-24.72%	0.0%
3 Years	-33.39%	-4.7%

Revvity Inc Key Stats

Check Revvity key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$89.23
Open	$89.055
Today's High	$90.29
Today's Low	$89.04
Market Capitalization	$10.4B
Today's Volume	$786.2K
52 Week High	$129.5
52 Week Low	$85.12
Revenue TTM	$2.8B
EBITDA	$834.9M
Earnings Per Share (EPS)	$2.3
PE Ratio	38.8
Dividend Yield	0.32%
Profit Margin	10.19%
Quarterly Earnings Growth YOY	0.02%
Return On Equity TTM	3.61%

Stock Returns calculator for Revvity Stock including INR - Dollar returns

The Revvity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Revvity investment value today

Current value as on today

₹80,564

Returns

₹19,436

(-19.44%)

Returns from Revvity Stock

₹24,720 (-24.72%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Revvity Stock

114%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Revvity Stock from India on INDmoney has increased by 114% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Revvity Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	953	-2.72	0.02%

Analyst Recommendation on Revvity Stock

Rating

Trend

Buy

64%Buy

36%Hold

0%Sell

Based on 25 Wall street analysts offering stock ratings for Revvity(by analysts ranked 0 to 5 stars)

Revvity Share Price Target

What analysts predicted

Upside of 29.59%

Target:

$116.81

Current:

$90.14

Revvity share price target is $116.81, a slight Upside of 29.59% compared to current price of $90.14 as per analysts' prediction.

Revvity Stock Insights

Price Movement
In the last 7 days, RVTY stock has moved down by -4.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 664.76M → 720.28M (in $), with an average increase of 7.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 42.23M → 53.94M (in $), with an average increase of 21.7% per quarter
RVTY vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 60.6%
RVTY vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 85.1% return, outperforming this stock by 118.9%
Price to Sales
ForRVTY every $1 of sales, investors are willing to pay $3.9, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Revvity Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$2.9B	↑ 3.8%
Net Income	$227.6M	↓ 4.36%
Net Profit Margin	7.89%	↓ 0.67%

	FY20	Y/Y Change
Revenue	$2.7B	↓ 7.64%
Net Income	$727.9M	↑ 219.87%
Net Profit Margin	27.33%	↑ 19.44%

	FY21	Y/Y Change
Revenue	$3.8B	↑ 43.73%
Net Income	$943.2M	↑ 29.57%
Net Profit Margin	24.64%	↓ 2.69%

	FY22	Y/Y Change
Revenue	$3.3B	↓ 13.48%
Net Income	$569.2M	↓ 39.65%
Net Profit Margin	17.19%	↓ 7.45%

	FY23	Y/Y Change
Revenue	$2.8B	↓ 16.95%
Net Income	$693.1M	↑ 21.77%
Net Profit Margin	25.2%	↑ 8.01%

	FY24	Y/Y Change
Revenue	$2.8B	↑ 0.16%
Net Income	$270.4M	↓ 60.99%
Net Profit Margin	9.81%	↓ 15.39%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$649.9M	↓ 6.61%
Net Income	$26.0M	↓ 66.89%
Net Profit Margin	4.0%	↓ 7.29%

	Q2 FY24	Q/Q Change
Revenue	$691.7M	↑ 6.43%
Net Income	$55.4M	↑ 112.82%
Net Profit Margin	8.0%	↑ 4.0%

	Q3 FY24	Q/Q Change
Revenue	$684.0M	↓ 1.1%
Net Income	$94.4M	↑ 70.46%
Net Profit Margin	13.8%	↑ 5.8%

	Q4 FY24	Q/Q Change
Revenue	$729.4M	↑ 6.63%
Net Income	$94.6M	↑ 0.29%
Net Profit Margin	12.98%	↓ 0.82%

	Q1 FY25	Q/Q Change
Revenue	$664.8M	↓ 8.86%
Net Income	$42.2M	↓ 55.37%
Net Profit Margin	6.35%	↓ 6.63%

	Q2 FY25	Q/Q Change
Revenue	$720.3M	↑ 8.35%
Net Income	$53.9M	↑ 27.73%
Net Profit Margin	7.49%	↑ 1.14%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.4B	↑ 4.11%

	FY20	Y/Y Change
Profit	$1.7B	↑ 24.63%

	FY21	Y/Y Change
Profit	$2.4B	↑ 39.89%

	FY22	Y/Y Change
Profit	$2.0B	↓ 18.25%

	FY23	Y/Y Change
Profit	$1.5B	↓ 22.62%

	FY24	Y/Y Change
Profit	$1.5B	↓ 0.13%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$355.0M	↓ 7.41%

	Q2 FY24	Q/Q Change
Profit	$385.5M	↑ 8.58%

	Q3 FY24	Q/Q Change
Profit	$384.8M	↓ 0.18%

	Q4 FY24	Q/Q Change
Profit	$412.3M	↑ 7.14%

	Q1 FY25	Q/Q Change
Profit	$375.5M	↓ 8.91%

	Q2 FY25	Q/Q Change
Profit	$392.6M	↑ 4.53%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$363.5M	↑ 16.86%
Investing Cash Flow	$-487.6M	↑ 205.0%
Financing Cash Flow	$150.1M	↓ 183.76%

	FY20	Y/Y Change
Operating Cash Flow	$892.2M	↑ 145.46%
Investing Cash Flow	$-504.5M	↑ 3.47%
Financing Cash Flow	$-202.9M	↓ 235.13%

	FY21	Y/Y Change
Operating Cash Flow	$1.4B	↑ 58.12%
Investing Cash Flow	$-4.1B	↑ 715.22%
Financing Cash Flow	$2.9B	↓ 1550.01%

	FY22	Y/Y Change
Operating Cash Flow	$679.8M	↓ 51.81%
Investing Cash Flow	$-132.9M	↓ 96.77%
Financing Cash Flow	$-661.8M	↓ 122.5%

	FY23	Y/Y Change
Operating Cash Flow	$91.3M	↓ 86.57%
Investing Cash Flow	$1.3B	↓ 1088.72%
Financing Cash Flow	$-947.1M	↑ 43.11%

	FY24	Y/Y Change
Operating Cash Flow	$628.3M	↑ 588.38%
Investing Cash Flow	$776.2M	↓ 40.91%
Financing Cash Flow	$-1.1B	↑ 19.12%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$147.6M	↓ 24.95%
Investing Cash Flow	$-18.2M	↓ 95.62%
Financing Cash Flow	$-35.0M	↑ 78.51%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$158.6M	↑ 7.49%
Investing Cash Flow	$121.5M	↓ 768.23%
Financing Cash Flow	$-26.5M	↓ 24.33%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$147.9M	↓ 6.77%
Investing Cash Flow	$690.2M	↑ 468.09%
Financing Cash Flow	$-873.7M	↑ 3197.74%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$174.2M	↑ 17.81%
Investing Cash Flow	$-17.3M	↓ 102.51%
Financing Cash Flow	$-193.0M	↓ 77.91%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$128.2M	↓ 26.44%
Investing Cash Flow	$-6.4M	↓ 63.19%
Financing Cash Flow	$-163.7M	↓ 15.2%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$133.5M	↑ 4.2%
Investing Cash Flow	$-9.5M	↑ 48.84%
Financing Cash Flow	$-302.4M	↑ 84.77%

Revvity Technicals Summary

Sell

Neutral

Buy

Revvity is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Revvity Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Revvity Inc	2.55%	-18.34%	-24.72%	-33.39%	-24.5%
Agilent Technologies Inc.	9.48%	-0.51%	-9.55%	-2.51%	24.3%
Idexx Laboratories, Inc.	20.87%	47.74%	37.7%	84.56%	62.07%
Thermo Fisher Scientific, Inc.	5.33%	-5.93%	-18.77%	-10.56%	13.57%
Danaher Corp.	4.43%	0.1%	-22.08%	-24.82%	-1.19%
Iqvia Holdings Inc.	2.55%	3.11%	-23.4%	-9.93%	15.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Revvity Inc	38.8	38.8	0.64	4.87	0.04	0.02	0.0	64.95
Agilent Technologies Inc.	29.29	29.29	1.84	5.57	0.2	0.08	0.0	22.46
Idexx Laboratories, Inc.	53.78	53.78	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.33	28.33	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.68	43.68	2.06	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.61	27.61	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Revvity Inc	Buy	$10.4B	-24.5%	38.8	10.19%
Agilent Technologies Inc.	Buy	$35.7B	24.3%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	62.07%	53.78	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.9B	13.57%	28.33	15.24%
Danaher Corp.	Buy	$147.0B	-1.19%	43.68	14.21%
Iqvia Holdings Inc.	Buy	$32.4B	15.42%	27.61	7.88%

Revvity Dividend announcements

Revvity Dividends December, 2025
In the quarter ending December,2025. Revvity has declared dividend of $0.07

About Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company's Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in oncology, screening newborns for rare genetic conditions, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BioQule, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPatternTM, Evolution Evoya, explorer, Fontus, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Omni Bead Ruptor, Omni Bead Ruptor Elite, Omni Tip, Pannoramic, Panthera Puncher, PG-Seq, PG-Find, PreNAT II, Prime, Protein Clear, ProteinEXact, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR2D, and Zephyr brands. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Mass

Organization	Revvity
Employees	11000
CEO	Dr. Prahlad R. Singh Ph.D.
Industry	Miscellaneous

Key Management of Revvity Inc

Name	Title
Dr. Prahlad R. Singh Ph.D.	CEO, President & Director
Mr. Maxwell Krakowiak	Senior VP & CFO
Mr. Tajinder S. Vohra	Senior Vice President of Global Operations
Mr. Joel S. Goldberg	Senior VP of Administration, General Counsel & Secretary
Ms. Miriame Victor	Senior VP & Chief Commercial Officer
Mr. Bryan A. Kipp	Senior VP of Technology & Licensing
Ms. Madhuri Hegde FACMG, Ph.D.	Senior VP & Chief Scientific Officer
Mr. Stephen Barr Willoughby	Senior VP of Investor Relations & Head of ESG
Ms. Magali Four	Senior VP and Chief People & Culture Officer
Mr. Robert Francis Friel	Advisor

Important FAQs about investing in RVTY Stock from India :

What is Revvity share price today?

Revvity share price today is $90.14 as on August 30, 2025 at 1:29 am IST at the close of the market. Revvity share today touched a day high of $90.29 and a low of $89.04.

What is the 52 week high and 52 week low for Revvity share?

Revvity share touched a 52 week high of $129.50 and a 52 week low of $85.12. Revvity stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $90.14, lower by 30.39% versus the 52 week high.

How to invest in Revvity Stock (RVTY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Revvity on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Revvity Shares that will get you 0.0166 shares as per Revvity share price of $90.14 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Revvity Stock (RVTY) from India?

Indian investors can start investing in Revvity (RVTY) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Revvity stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Revvity share’s latest price of $90.14 as on August 30, 2025 at 1:29 am IST, you will get 0.1109 shares of Revvity. Learn more about fractional shares .

What are the returns that Revvity has given to Indian investors in the last 5 years?

Revvity stock has given -24.5% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?